Related Experiment Video
Updated: Jan 11, 2026

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
Published on: September 14, 2018
Enhanced In Vivo Tetanus Toxin Neutralizing Potency of an Anti-Toxin Monoclonal Antibody Following Antibody
Somayeh Ghotloo1,2, Mohammad Mehdi Amiri1, Danesh Hassani1
1Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Abstract:
Each immunoglobulin molecule consists of two functional independent regions, including variable and constant regions. Toxin neutralization by antibody is mainly mediated by the variable regions. Here, we report that constant region chimerization of a mouse anti-tetanus toxin monoclonal antibody (MAb), 1F3E3, confers enhanced in vivo toxin neutralizing activity of the chimeric MAb compared to its parental murine counterpart. A mouse-human chimeric MAb, c-1F3E3, was generated by recombinant DNA technology and its structural and functional characteristics, including affinity constant, reactivity pattern to tetanus toxin fragments, inhibiting the toxin binding to GT1b ganglioside receptors as well as in vivo toxin neutralizing activity in mice were assessed and compared with those of the murine MAb. Both the murine and chimeric MAbs displayed similar reactivity patterns as well as similar toxin binding affinity constant. The target epitope of both MAbs was located in fragment C of the toxin and both were able to inhibit binding of the toxin to GT1b ganglioside at a comparable level. While 1F3E3 MAb failed to neutralize the toxin in vivo, the chimeric MAb (c-1F3E3) showed a strong and dose-dependent toxin neutralizing potency leading to improved protection and survival in mice. Mouse-human chimerization of an anti-tetanus toxin MAb improved its in vivo toxin neutralizing activity, implying contribution of the constant region of the MAb in toxin neutralization.
More Related Videos
09:25Detection and Enrichment of Rare Antigen-specific B Cells for Analysis of Phenotype and Function
Published on: February 16, 2017
10:30A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
Published on: December 27, 2013
Related Concept Videos
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...